Immune system – non-specific immunological interaction

Immune system – non-specific immunological interaction refers to a broad pharmacological category where therapeutic agents modulate the host's immune response without targeting a single, specific molecular receptor or enzyme (StatPearls, 2023). This category encompasses the activation of the innate immune system, involving cells such as macrophages, neutrophils, and natural killer cells to provide a generalized defense against pathogens or malignant cells (NIH, 2024). Common examples include the use of Bacillus Calmette-Guérin (BCG) for bladder cancer, which stimulates a local and systemic immune response, and various vaccine adjuvants like aluminum salts that enhance antigen-specific responses by creating an "immunological spark" (PubMed, 2019). While these interactions are effective for boosting host immunity, they lack the precision of targeted therapies, often leading to systemic side effects such as fever or inflammation. In modern drug discovery, many agents once considered non-specific have been reclassified as their interactions with specific receptors, such as Toll-like receptors (TLRs) or STING, have been identified. Consequently, this term is often used in a legacy context or to describe complex biological products with pleiotropic effects.

Other names

Non-specific immunityInnate immune modulationNon-specific immunostimulationNon-specific immunological effect

Broad modulation of the innate immune system through the activation of pattern recognition receptors and cytokine signaling pathways to enhance or suppress general immune surveillance (StatPearls, 2023).